StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
JUNIPER.BO$196.00+0.49%
Fair $196.00+0.0%

JUNIPER.BO

JUNIPER.BO

Consumer Cyclical / LodgingBSE

$196.00

+0.95 (+0.49%)

Fairly Valued+0.0%Fair Value $196.00Fund rank 38/100 · Data gapFallback financials|
SA 35/D
F-Score: 7/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 23% · confianza 25%

FCF escenarios

weak_data · normalized FCF $2.0B · quality 75.3/100

Data gap 38/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 86/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

35/100

D

Piotroski

7/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is 4.9%, below the 5% threshold
Thesis & Journal · JUNIPER.BOLocal privado en este navegador · JUNIPER.BO
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$43.6B

P/E

30.8x

↑

EV/EBITDA

13.8x

↑

ROE

4.9%

↓

Gross Margin

74.8%

↑

Debt/Equity

0.42

↓
52-Week Range$196
$189$344

TradingView lightweight chart

JUNIPER.BO price, volumen y niveles de valoración

Último $196.00Periodo -50.7%
Fair value: $196.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2023–2026 · 3 años de histórico normalizado

Revenue CAGR

+16.4%

FCF CAGR

-8.6%

FCF margin

18.7%

FCF / Net income

1.39x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $10.48B · net income $1.42B · FCF $1.96B

2023-FY → 2026-FY

Gross margin

74.8%+5.1% pts

Operating margin

29.6%-1.2% pts

Net margin

13.5%+13.7% pts

FCF margin

18.7%-19.9% pts
MetricTTM
2026
2025
2024
2023
Income Statement
Revenue$10.48B$10.48B$9.44B$8.18B$6.65B
Net Income$1.42B$1.42B$712.9M$238.0M$-15.0M
EBITDA$4.01B$4.01B$3.68B$2.74B$2.55B
EPS——3.201.46-0.07
Gross Margin74.8%74.8%73.7%66.8%69.7%
Operating Margin29.6%29.6%24.1%27.5%30.8%
Net Margin13.5%13.5%7.5%2.9%-0.2%
Balance Sheet
Debt/Equity0.420.420.530.506.89
Current Ratio0.660.66———
Cash Flow
Free Cash Flow$1.96B$1.96B$1.79B$2.49B$2.57B
Returns
ROE4.9%4.9%2.6%0.9%-0.4%
Valuation
P/E30.8230.8283.14358.08—
EV/EBITDA13.8313.8320.0234.55—
P/B1.521.522.173.22—
Growth & Yield
Revenue Growth11.0%11.0%15.5%23.0%—
EPS Growth——119.2%2269.2%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -37.2%

Total return

-37.2%

Start / end P/E

n/dx → n/dx

EPS bridge

3.20 → n/d

Residual

-37.2%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-37.2%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.